| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.87▲ | 0.86▲ | 0.85▲ | 0.94▼ | 0.97▼ |
| MA10 | 0.87▲ | 0.83▲ | 0.79▲ | 0.99▼ | 1.08▼ |
| MA20 | 0.85▲ | 0.77▲ | 0.84▲ | 1.00▼ | 1.42▼ |
| MA50 | 0.82▲ | 0.92▼ | 1.00▼ | 1.16▼ | 2.10▼ |
| MA100 | 0.76▲ | 1.00▼ | 0.99▼ | 1.48▼ | 2.37▼ |
| MA200 | 0.83▲ | 1.00▼ | 1.07▼ | 1.86▼ | 6.67▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.026▲ | 0.023▲ | -0.007▼ | -0.026▼ |
| RSI | 62.552▲ | 57.621▲ | 49.472▼ | 41.775▼ | 33.788▼ |
| STOCH | 68.818 | 76.865 | 89.652▲ | 32.773 | 18.205▼ |
| WILL %R | -46.272 | -19.901▲ | -15.884▲ | -66.581 | -79.883▼ |
| CCI | 84.352 | 115.283▲ | 110.180▲ | -84.672 | -104.525▼ |
|
Monday, November 09, 2026 04:01 AM
Annovis Chairman of the Board invested $5.0 million as part of the underwritten public offering ; Company expects cash to fund operations through the pivotal Phase 3 Alzheimer’s ...
|
|
Thursday, November 05, 2026 09:26 AM
Canaccord Genuity is acting as sole bookrunner. Annovis intends to use the net proceeds to support continued clinical development of its investigational oral therapy buntanetap for Alzheimer’s disease ...
|
|
Thursday, November 05, 2026 05:06 AM
Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/11/26 | 0.9116 | 0.9248 | 0.8356 | 0.8764 | 2,251,744 |
| 06/11/26 | 0.70 | 0.8527 | 0.6301 | 0.8449 | 8,985,397 |
| 05/11/26 | 0.88 | 0.906 | 0.6161 | 0.6689 | 30,802,442 |
| 04/11/26 | 1.12 | 1.25 | 1.10 | 1.21 | 1,388,500 |
| 03/11/26 | 1.07 | 1.15 | 1.06 | 1.09 | 678,277 |
| 02/11/26 | 1.17 | 1.395 | 1.05 | 1.08 | 3,003,119 |
| 30/10/26 | 1.02 | 1.17 | 1.01 | 1.13 | 1,480,636 |
| 29/10/26 | 1.01 | 1.0499 | 1.00 | 1.02 | 1,482,414 |
| 28/10/26 | 0.98 | 1.03 | 0.98 | 1.02 | 911,371 |
| 27/10/26 | 0.95 | 1.03 | 0.95 | 1.00 | 912,809 |
|
|
||||
|
|
||||
|
|